EP4743476A1 - Kristallisierung von lacto-n-triose ii - Google Patents

Kristallisierung von lacto-n-triose ii

Info

Publication number
EP4743476A1
EP4743476A1 EP24738340.9A EP24738340A EP4743476A1 EP 4743476 A1 EP4743476 A1 EP 4743476A1 EP 24738340 A EP24738340 A EP 24738340A EP 4743476 A1 EP4743476 A1 EP 4743476A1
Authority
EP
European Patent Office
Prior art keywords
crystalization
lacto
triose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24738340.9A
Other languages
English (en)
French (fr)
Inventor
Tobias Seitz
Mischa Baier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chr Hansen AS
Original Assignee
Chr Hansen AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr Hansen AS filed Critical Chr Hansen AS
Publication of EP4743476A1 publication Critical patent/EP4743476A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
EP24738340.9A 2023-07-11 2024-07-11 Kristallisierung von lacto-n-triose ii Pending EP4743476A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23184691 2023-07-11
PCT/EP2024/069607 WO2025012361A1 (en) 2023-07-11 2024-07-11 Crystallization of lacto-n-triose ii

Publications (1)

Publication Number Publication Date
EP4743476A1 true EP4743476A1 (de) 2026-05-20

Family

ID=87245728

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24738340.9A Pending EP4743476A1 (de) 2023-07-11 2024-07-11 Kristallisierung von lacto-n-triose ii

Country Status (4)

Country Link
EP (1) EP4743476A1 (de)
KR (1) KR20260036551A (de)
CN (1) CN121712783A (de)
WO (1) WO2025012361A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405856B1 (de) * 2001-06-11 2018-09-26 Kyowa Hakko Bio Co., Ltd. Kristalle von oligosacchariden und verfahren zu deren herstellung
DK181566B1 (en) * 2021-12-21 2024-05-24 Dsm Ip Assets Bv Crystallization of LNnT
WO2023175130A1 (en) * 2022-03-17 2023-09-21 Dsm Ip Assets B.V. Crystalline lacto-n-triose ii

Also Published As

Publication number Publication date
WO2025012361A1 (en) 2025-01-16
KR20260036551A (ko) 2026-03-17
CN121712783A (zh) 2026-03-20

Similar Documents

Publication Publication Date Title
EP4069212A4 (de) Inhibitoren von hif-2alpha
EP4555783A4 (de) Bereitstellung von systeminformationen
EP4240363A4 (de) 7-phenylsubstituierte 2-aminochinazolinhemmer von hpk1
EP4333821A4 (de) Inhibitoren von sars-cov-2
EP4107943A4 (de) Kodierung von benachbarten teilbildern
EP4360641A4 (de) Verwendung von mazdutid
EP4370686A4 (de) Stöchiometrische expression von messenger-polycistronen
EP4344477A4 (de) Verbesserte signalisierung von zusätzlichen erweiterungsinformationen
EP4305043A4 (de) Reinigung von sialooligosacchariden
EP4452967A4 (de) Inhibitoren von sars-cov-2
EP4240361A4 (de) 7-azolsubstituierte 2-aminochinazolinhemmer von hpk1
EP4514131A4 (de) Modifizierte freisetzung von ascarosiden
EP4384164A4 (de) Inhibitoren von hypoxieinduzierbaren faktoren
EP4349335A4 (de) Verwendung von 5-nitro-8-hydroxychinolin
EP4555758A4 (de) Bereitstellung von systeminformationen
EP4115257C0 (de) Abfangen von drohnen
EP4476268A4 (de) Abbau von beta-catenin-protein
EP4189080A4 (de) Varianten von cas-nuklease
EP4482497A4 (de) Protacs von malt1
EP4573772A4 (de) Konfiguration von kanalstatusinformationen
EP4384396A4 (de) Integration von generativ gefertigten komponenten
EP4338083C0 (de) Abschwächung von fpga-bezogenen risiken
EP4298057C0 (de) Sequestrierung von co
EP4271679A4 (de) Amorphe form von pretomaniden
EP4107630A4 (de) Akkumulation von bitstrings

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE